BBIO Form 4: Neil Kumar RSU Vesting and Tax Withholding Details
Rhea-AI Filing Summary
BridgeBio Pharma director and CEO Neil Kumar reported transactions on 08/16/2025 showing vesting and tax-withholding activity tied to Restricted Stock Units (RSUs). A total of 64,697 RSU shares vested (reported as acquisition), and 32,855 shares were withheld to satisfy tax obligations at an indicated price of $51.32 per share. After these transactions the reporting person directly beneficially owned 282,101 shares and indirectly beneficially owned 4,718,447 and 915,686 shares through two trusts, of which he is co-trustee. Multiple tranches of RSUs continue to vest quarterly with no expiration.
Positive
- Vesting of 64,697 RSU shares increases the executive's aligned equity stake
- Large indirect holdings (4,718,447 and 915,686 shares) demonstrate substantial long-term economic exposure
- RSUs vest quarterly with no expiration, indicating ongoing alignment with company performance
Negative
- 32,855 shares withheld to satisfy taxes at $51.32 reduced direct beneficial ownership
- Potential dilution from vested RSUs as they convert into common stock
Insights
TL;DR: Insider vested RSUs increased share exposure while a routine tax-withholding sale reduced direct holdings.
The filing documents customary executive compensation mechanics: vesting of 64,697 RSU shares increases potential share issuance and long-term alignment, while withholding of 32,855 shares at $51.32 is a non-dispositive tax-related disposition that lowers direct share count. The large indirect holdings via two trusts (totaling 5,634,134 shares) indicate substantial overall economic exposure despite the net change in direct shares. These transactions are typical for executive equity compensation and not an indicator of a material change in control or strategy.
TL;DR: Transactions reflect standard vesting and tax withholding; disclosure and trust structures are properly noted.
Form 4 shows clear disclosure of direct and indirect ownership and the nature of indirect holdings through revocable and irrevocable trusts, with the required disclaimer of beneficial ownership limited to pecuniary interest. The continuing quarterly vesting schedule and lack of expiration for RSUs are governance-relevant for dilution modeling. No departures, option exercises for cash proceeds, or other atypical governance events are reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 33,544 | $0.00 | -- |
| Exercise | Restricted Stock Units | 19,599 | $0.00 | -- |
| Exercise | Restricted Stock Units | 11,554 | $0.00 | -- |
| Exercise | Common Stock | 64,697 | $0.00 | -- |
| Tax Withholding | Common Stock | 32,855 | $51.32 | $1.69M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 64,697 shares of Common Stock underlying the Reporting Person's RSUs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2025. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
